After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
VERA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Vera Therapeutics Inc is $2.21B. A total of 0.65 million shares were traded on the day, compared to an average of 803.22K shares.
In the most recent transaction, Fordyce Marshall sold 17,500 shares of VERA for 41.74 per share on Jan 08 ’25. After the transaction, the PRESIDENT AND CEO now owns 143,603 company shares. In a previous transaction on Jan 08 ’25, MARSHALL FORDYCE bought 17,500 shares at 42.10 per share.
Among the insiders who sold shares, Fordyce Marshall disposed of 17,500 shares on Dec 18 ’24 at a per-share price of $43.07. This resulted in the PRESIDENT AND CEO holding 85,942 shares of VERA after the transaction. In another insider transaction, MARSHALL FORDYCE bought 17,500 shares at $43.91 per share on Dec 18 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, VERA has a high of $51.61 and a low of $20.48.
As of this writing, VERA has an earnings estimate of -$0.73 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.62 per share and a lower estimate of -$0.9.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. VERA’s latest balance sheet shows that the firm has $79.67M in Cash & Short Term Investments as of fiscal 2021. There were $4.92M in debt and $7.69M in liabilities at the time. Its Book Value Per Share was $5.25, while its Total Shareholder’s Equity was $69.59M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERA is Buy with a score of 4.83.
